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The Golgi S-acylation machinery comprises 
zDHHC enzymes with major differences in 
substrate affinity and S-acylation activity
Kimon Lemonidisa, Oforiwa A. Gorlekua, Maria C. Sanchez-Pereza, Christopher Grefenb,  
and Luke H. Chamberlaina
aStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, United 
Kingdom; bZMBP Developmental Genetics, D-72076 Tuebingen, Germany
ABSTRACT S-acylation, the attachment of fatty acids onto cysteine residues, regulates pro-
tein trafficking and function and is mediated by a family of zDHHC enzymes. The S-acylation 
of peripheral membrane proteins has been proposed to occur at the Golgi, catalyzed by an 
S-acylation machinery that displays little substrate specificity. To advance understanding of 
how S-acylation of peripheral membrane proteins is handled by Golgi zDHHC enzymes, we 
investigated interactions between a subset of four Golgi zDHHC enzymes and two S-acylated 
proteins—synaptosomal-associated protein 25 (SNAP25) and cysteine-string protein (CSP). 
Our results uncover major differences in substrate recognition and S-acylation by these zD-
HHC enzymes. The ankyrin-repeat domains of zDHHC17 and zDHHC13 mediated strong and 
selective interactions with SNAP25/CSP, whereas binding of zDHHC3 and zDHHC7 to these 
proteins was barely detectable. Despite this, zDHHC3/zDHHC7 could S-acylate SNAP25/CSP 
more efficiently than zDHHC17, whereas zDHHC13 lacked S-acylation activity toward these 
proteins. Overall the results of this study support a model in which dynamic intracellular lo-
calization of peripheral membrane proteins is achieved by highly selective recruitment by a 
subset of zDHHC enzymes at the Golgi, combined with highly efficient S-acylation by other 
Golgi zDHHC enzymes.
INTRODUCTION
S-acylation, a reversible posttranslational modification (PTM) involv-
ing the attachment of fatty acids onto cysteine residues, plays a ma-
jor role in regulating the trafficking and function of modified pro-
teins (Linder and Deschenes, 2007; Fukata and Fukata, 2010; Salaun 
et al., 2010). This PTM is commonly referred to as palmitoylation, 
reflecting the fact that palmitic acid is the predominant fatty acid 
added to proteins in this way (Muszbek et al., 1999). Proteomic 
analyses have identified upward of 300 S-acylated proteins (Kang 
et al., 2008; Martin and Cravatt, 2009; Yount et al., 2010), which in-
clude both transmembrane and peripheral membrane proteins. For 
peripheral membrane proteins, a major function of S-acylation is to 
provide a stable membrane anchor; hence this PTM is essential for 
membrane association of signaling molecules such as H-Ras, N-Ras, 
TC10, and GA subunits and for membrane fusion proteins such as 
synaptosomal-associated protein 25 (SNAP25) and cysteine-string 
protein (CSP; Salaun et al., 2010).
S-acylation reactions in mammals are catalyzed by a family of 24 
zDHHC S-acyl-transferase enzymes (Fukata et al., 2004). These en-
zymes are predicted to be polytopic membrane proteins, with four 
to six transmembrane domains and a conserved 51–amino acid 
zDHHC-CR domain (aspartate-histidine-histidine-cysteine motif in a 
cysteine-rich, zinc finger–like domain). At the heart of this zDHHC-
CR domain is a highly conserved DHHC tetrapeptide that is critical 
for S-acylation activity. Although the exact mechanism of S-acylation 
is not known, it has been long assumed, and recently demonstrated 
for purified zDHHC2, zDHHC3 and yeast Erf2, that it involves a 
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CSP/SNAP25 interactions were found to be very strong and specific, 
since growth of CSP/SNAP25–zDHHC17 yeast matings was barely 
affected by methionine-induced reduction of zDHHC17 expression; 
furthermore, their growth was more prominent than the positive con-
trol (NubI–zDHHC17) matings (Figure 2, B and C). Specificity of the 
reported interaction was assessed by comparison with two other S-
acylated proteins that are not known to be substrates of zDHHC17 
(N-RAS, TC10). In contrast to SNAP25 and CSP, there was very little 
interaction observed between zDHHC17 and either N-RAS or TC10; 
indeed, at the highest methionine concentration, yeast growth was 
barely detectable (Figure 2C). To eliminate the possibility that the 
strong zDHHC17 interaction with CSP and SNAP25, observed by 
SUS, may be due to their increased membrane association caused by 
zDHHC-catalyzed S-acylation, we also assessed the foregoing inter-
actions when the catalytic cysteine of zDHHC17 was mutated (C467A). 
This mutation had no effect on either the strength or the specificity of 
zDHHC17 interaction toward CSP and SNAP25 (Figure 2C).
The N-terminal ankyrin-repeat domain of zDHHC17 is 
necessary and sufficient for interaction with SNAP25 and CSP
To identify the region of zDHHC17 involved in interaction with CSP 
and SNAP25, we constructed a series of zDHHC17 truncation mu-
tants lacking the extreme N-terminus before the ankyrin repeat 
(ANK) domain (17-$N), the N-terminal region containing the ANK 
domain (17-$NAnk), the whole region after the fourth transmem-
brane domain and including the zDHHC domain (17-$CDHHC), or 
the C-terminal cytosolic region (17-$C; Figure 3A); all of these 
mutants were expressed at similar levels to wild-type (17-WT) 
two-step mechanism in which the zDHHCs form an acyl–enzyme in-
termediate (autoacylation), with the acyl group later transferred to 
the target protein (Mitchell et al., 2010; Jennings and Linder, 2012). 
Furthermore, the kinetics of autoacylation suggest a stoichiometry 
of one acyl group per enzyme molecule (Mitchell et al., 2010).
zDHHC enzymes are associated with the endoplasmic reticulum, 
Golgi, plasma membrane, and endosomes (Ohno et al., 2006; 
Greaves et al., 2011), with the catalytic zDHHC-CR domain facing 
the cytoplasm (Mitchell et al., 2006). Recent work has indicated that 
the Golgi apparatus is a hotspot for the S-acylation of peripheral 
membrane proteins, with the corresponding zDHHC enzymes being 
incapable of recognizing structural features of substrate proteins, 
surrounding the target cysteine(s); therefore, it has been suggested 
that zDHHC enzymes may lack substrate specificity for certain S-
acylated proteins (Rocks et al., 2010). On the contrary, another study 
revealed specific substrate interactions and/or S-acylation activity 
for a subset of neuronal zDHHC enzymes (Huang et al., 2009).
To advance our understanding of how S-acylation reactions are 
handled by Golgi zDHHC enzymes, we examined the interactions 
between a subset of these enzymes and two S-acylated peripheral 
membrane proteins (SNAP25 and CSP). The specific aims of the 
study were to 1) determine whether individual Golgi zDHHC en-
zymes exhibit selective interactions with either of these two substrate 
proteins, 2) identify potential mechanisms involved in substrate rec-
ognition, and 3) determine the importance of zDHHC–substrate 
binding for subsequent S-acylation activity. The results presented 
suggest that there are marked differences in substrate specificity and 
S-acylation efficiency of Golgi zDHHC enzymes that modify periph-
eral membrane proteins. These enzymes displayed either strong and 
selective interactions with their substrates or nearly undetectable 
binding. Surprisingly, a complex nonlinear relationship was uncov-
ered between the strength of zDHHC–substrate interactions and 
subsequent S-acylation, implying that Golgi zDHHC enzymes have 
major differences in their intrinsic S-acyl-transferase activity. The si-
multaneous expression of these two groups of zDHHC enzymes 
might therefore be important to allow the Golgi S-acylation machin-
ery to modify a wide and diverse set of substrate proteins.
RESULTS
zDHHC17 displays strong and specific interaction with CSP 
and SNAP25
To assess binding of peripheral membrane proteins to Golgi zDHHC 
enzymes, we used the very well characterized S-acylated proteins 
cysteine-string protein (CSP) and SNAP25, and the Golgi-localized 
S-acyl-transferases zDHHC3, zDHHC7, and zDHHC17, since all 
these three enzymes can S-acylate both CSP (Greaves et al., 2008) 
and all members of the SNAP25 family (Greaves et al., 2010). By 
using hexahistidine (His6)-tagged forms of SNAP25/CSP to capture 
hemagglutinin (HA)-tagged versions of the foregoing enzymes from 
HEK293T cell lysates, we found that only zDHHC17 displayed de-
tectable interaction with SNAP25 (Figure 1A) and CSP (Figure 1B).
To confirm the CSP/SNAP25 binding preference toward zDHHC17 
over other Golgi zDHHC enzymes, we also used the mating-based 
split-ubiquitin system (SUS) in yeast; in this system, interactions of a 
bait-transmembrane protein (zDHHC enzyme) with another protein 
prey (CSP/SNAP25) can be assessed in vivo due to interaction-de-
pendent reporter activation of genes required for yeast growth (Figure 
2A; more detailed description of the SUS is given in Materials and 
Methods). SUS analysis also revealed preferential binding of SNAP25 
and CSP to zDHHC17, than to zDHHC3, and this was even more 
prominent when zDHHC3/zDHHC17 expression was restricted by ad-
dition of methionine in the growth medium (Figure 2B). zDHHC17–
FIGURE 1: SNAP25 and CSP bind preferentially to zDHHC17 
compared to zDHHC3 or zDHHC7. (A) HA-tagged zDHHCs were 
transfected into HEK293T cells, and corresponding cell lysates were 
incubated with Ni2+-NTA beads and either 75 µg of His6-SNAP25 or 
equivalent volume of PBS; 1/16 of input and 1/3 of bound fractions 
were subjected to SDS–PAGE, transfer to nitrocellulose, Ponceau-S 
staining, and Western blot analysis using HA antibody. (B) HA-tagged 
zDHHCs were transfected into HEK293T cells, and corresponding 
lysates were incubated with Ni2+-NTA beads that had been 
preincubated with either 75 µg of His6-CSP or an equivalent volume 
of PBS; 1/16 of input and 1/3 of bound fractions were subjected to 
SDS–PAGE, transfer to nitrocellulose, Ponceau-S staining, and 
Western blot analysis using HA antibody. Positions of molecular 
weight standards are shown on the left of Western blots.
3872 | K. Lemonidis et al. Molecular Biology of the Cell
FIGURE 2: Assessment of zDHHC17 specificity toward SNAP25 and CSP, using the mating-based SUS. (A) Schematic 
illustration of the SUS. Ubiquitin is split into halves, with the Nub half fused to the N-terminus of a prey protein and the 
Cub half fused between a bait membrane protein and a PLV composed of protein A, a DNA-binding domain (LexA), and a 
transcriptional activating domain (VP16). Coexpression of the bait (e.g., zDHHC enzyme) with the prey (e.g., S-acylated 
substrate) could lead, upon interaction, to the reassembly of ubiquitin, which can now be recognized by ubiquitin-specific 
proteases. Spontaneous reassembly of ubiquitin cannot occur, due to a single amino acid substitution in Nub (I13G). The 
cleavage of ubiquitin will release the transcriptional reporter complex PLV, leading to the activation of auxotrophy reporter 
genes, allowing detection of interaction via growth analysis. Expression of bait and prey proteins can be assessed by 
Western blotting, using anti-VP16 and anti-HA antibodies, respectively. (B) SUS assessment of CSP and SNAP25 
interactions with zDHHC3 and zDHHC17. Diploid yeast at corresponding OD600 was dropped on SD medium 
supplemented with adenine and histidine to verify equal dropping densities, and on SD medium (supplemented or not 
with methionine) to verify interactions. Plates were scanned after incubation at 30°C for the number of days indicated. 
Spontaneous reassembly of the C-terminal ubiquitin of zDHHC17-Cub-PLV with wild-type (NubI) or mutated (NubG) 
N-terminal ubiquitin was assessed in parallel. Expression of Cub-PLV, C-terminally tagged bait (zDHHC17) and NubG-
2HA–tagged preys from haploid-yeast lysates was assessed by Western blotting using anti-VP16 and anti-HA antibodies, 
respectively. Positions of molecular weight markers are shown on the left. (C) SUS assessment of zDHHC17 (wild type and 
C467A catalytically inactive mutant) interaction with CSP, SNAP25, N-RAS, and TC10 and corresponding Western blots.
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reported a small but significant decrease in SNAP25 S-acylation in 
brain samples from zDHHC13-knockout mice (Sutton et al., 2013), 
which indicates that zDHHC13 may contribute to SNAP25 S-acyla-
tion in vivo, possibly via interaction to zDHHC13’s ANK domain. To 
determine whether zDHHC13 interacts with SNAP25 and CSP, 
we also assessed with SUS interactions of this enzyme with these 
substrates. zDHHC13 was expressed quite poorly in yeast but at 
comparable levels to zDHHC7 (Figure 5B, right), which allowed 
comparison between these two enzymes with respect to CSP/
SNAP25 binding. SUS analysis revealed that zDHHC13 interacts 
with CSP and SNAP25 and, furthermore, that these interactions are 
much stronger than the ones observed for zDHHC7 (Figure 5B, 
left). In addition, the much increased growth of corresponding zD-
HHC13-CSP/SNAP25 matings compared with positive control ones 
(NubI-zDHHC13) suggests a very strong and specific zDHHC13 in-
teraction with these two proteins (Figure 5B). We further assessed 
with SUS, using zDHHC13 truncation mutants (Figure 5A), whether 
the ANK-containing cytosolic region or the zDHHC–CR and C-ter-
minal regions are important for these interactions. The zDHHC13 
truncation mutants were expressed at higher than wild-type levels 
(Figure 5C, right), and thus required different growth periods; how-
ever, despite these expression-caused limitations, it was clear that 
zDHHC13 interaction was lost after removal of its N-terminus and 
ANK domains (13-$NAnk) but not after removal of its zDHHC-CR 
and C-terminal domains (13-$CDHHC; Figure 5C, left). The forego-
ing data suggest that the N-terminal region containing the ANK 
domain of zDHHC13 is also essential and sufficient for CSP and 
SNAP25 interaction.
To further confirm the interactions of zDHHC13’s ANK domain 
with CSP and SNAP25, and compare the interaction strength in a 
more direct way to zDHHC17’s ANK domain, we used pull-down 
assays with purified His6-tagged CSP/SNAP25 to capture N-termi-
nal HA-tagged zDHHC17/13 fragments (Figure 5A) from HEK293T 
lysates. These assays revealed that the zDHHC13 and zDHHC17 
NAnk regions bind with similar strength to either SNAP25 
(Figure 5D) or CSP (Figure 5E); binding of full-length zDHHC13 to 
SNAP25 and CSP was also confirmed using the same approach 
(Figure 5, D and E).
zDHHC3 and zDHHC7 can S-acylate SNAP25 and CSP more 
efficiently than zDHHC17
Surprisingly, when zDHHC3, 7, 13, and 17 S-acylation efficiencies 
toward SNAP25 and CSP were compared in mammalian cells, it was 
found that zDHHC3 and zDHHC7 were significantly more active 
against these substrates than zDHHC17 (Figure 6, A and B); 
zDHHC13, on the other hand, was found to be inactive toward these 
substrates (Figure 6, A and B), as previously reported (Greaves et al., 
2008, 2010). Levels of zDHHC3/7 autoacylation were also higher, 
with zDHHC17/13 autoacylation being below detection level 
(Figure 6A). Thus differences in S-acylation efficiencies of zDHHC3, 
zDHHC7, zDHHC13, and zDHHC17 toward CSP and SNAP25 seem 
to be disproportional to their differences in substrate binding. 
Furthermore, the higher S-acylation activity of zDHHC3 and 
zDHHC7, despite their reduced substrate interactions, implies that 
these enzymes have a much greater S-acyl-transferase activity than 
zDHHC17 and zDHHC13.
The N-terminal ANK-containing domains of zDHHC17 and 
zDHHC13 are not functionally interchangeable
Because both zDHHC13 and zDHHC17 can interact strongly with 
SNAP25 and CSP via their ANK domains, we examined whether 
their N-terminal cytosolic regions (which contain their ANK domain) 
zDHHC17-Cub-PLV (Figure 3B, right). The yeast growth patterns 
showed that all zDHHC17 truncation mutants, with the exception 
of 17-$NAnk, interacted with SNAP25 and CSP with efficiency 
similar to wild-type zDHHC17 (17-WT). The 17-$NAnk mutant 
showed a marked loss of interaction with both substrate proteins, 
which was clearly apparent when zDHHC17 expression was re-
stricted by addition of 50 µM methionine (Figure 3B, left). Thus the 
ANK domain of zDHHC17 is essential for interaction with both 
SNAP25 and CSP.
The finding that the zDHHC17 construct lacking both the 
zDHHC-CR domain and C-terminus (17-$CDHHC) interacted with 
SNAP25 and CSP suggests that the ANK domain is sufficient for in-
teraction with these substrates. To test this, and confirm the results 
of the SUS, we prepared a glutathione S-transferase (GST)–tagged 
version (GST-17NAnk) of the cytosolic N-terminus of zDHHC17 
(residues 11–305), and incubated it with a rat brain lysate. Immuno-
blotting revealed that the GST-17NAnk construct (but not GST 
alone) captured SNAP25, and to a lesser degree CSP, but not other 
non–zDHHC17-interacting proteins (like synuclein) from the brain 
lysate (Figure 3C). We assumed that the very weak binding of CSP 
to GST-17NAnk may be due to the extensive S-acylation of this pro-
tein in brain tissue (Greaves et al., 2012), and this modification may 
hinder its interaction with zDHHC17’s ANK domain. Indeed, when 
assessing binding of palmitoylated and nonpalmitoylated myc-CSP 
to GST-17NAnk, we observed sixfold-lower binding of palmitoy-
lated CSP, irrespective of starting amount of palmitoylated and non-
palmitoylated CSP (Figure 3D). Given that removal of the extreme 
N-terminus of zDHHC17 (17-$N) did not alter zDHHC17 interaction 
with either CSP or SNAP25 (Figure 3B), these results indicate that 
the ANK domain of zDHHC17 is not only essential, but is also suffi-
cient for substrate binding. Furthermore, the decrease in the in vitro 
binding of GST-17NAnk to S-acylated CSP might indicate a possible 
mechanism of in vivo zDHHC17 function, by which substrate can be 
disassociated from enzyme upon modification.
The ANK domain and C-terminus of zDHHC17 are required 
for S-acylation of SNAP25 and CSP
Because the ANK domain of zDHHC17 is both essential and ade-
quate for substrate binding, it would be expected that zDHHC17 
lacking this would not be able to S-acylate its substrates. To test 
this, we assessed the ability of each of the zDHHC17 truncation 
mutants (apart from $CDHHC, which lacks the catalytic domain) to 
induce S-acylation of enhanced green fluorescent protein (EGFP)–
tagged SNAP25 and CSP, upon coexpression in HEK293T cells. 
Deletion of zDHHC17’s N-terminal region containing the ANK do-
main (17-$NAnk) resulted in a significant loss of both SNAP25 and 
CSP S-acylation; surprisingly, however, deletion of the C-terminus 
(17-$C) resulted in significant loss of S-acylation of these substrates 
too (Figure 4, A and B). Hence, although the ANK domain of 
zDHHC17 is required for both substrate binding and subsequent 
S-acylation of SNAP25 and CSP, the C-terminus of zDHHC17 is in-
volved only in S-acyl-transferase activity of zDHHC17, at least to-
ward these substrates. None of these zDHHC17 truncations 
affected the Golgi localization of exogenous zDHHC17 in HEK293T 
cells (Figure 4C).
zDHHC13 also interacts with SNAP25 and CSP via its 
N-terminal region containing an ANK domain
We and others previously reported that coexpression of zDHHC13 
with SNAP25 or CSP in mammalian cells does not lead to a signifi-
cant increase in S-acylation of these substrates (Greaves et al., 
2008, 2010; Huang et al., 2009). However, more recent work 
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FIGURE 3: The ANK domain of zDHHC17 is both necessary and sufficient for binding to CSP and SNAP25.  
(A) Schematic diagram of zDHHC17 truncation mutants used for SUS analysis. (B) Detection of CSP and SNAP25 
interactions with zDHHC17 wild type (17-WT) and 17-$N, 17-$NAnk, 17-$CDHHC, and 17-$C truncation mutants using 
SUS (growth assay). zDHHC17– CSP/SNAP25 matings at corresponding OD600 were dropped on SD medium 
supplemented with adenine and histidine to verify equal dropping densities, and on SD medium (supplemented or not 
with methionine) to verify interactions. Plates were scanned after incubation at 30°C for 2 d. Spontaneous reassembly of 
the C-terminal ubiquitin of zDHHC17-Cub-PLV with wild-type (NubI) or mutated (NubG) N-terminal ubiquitin was 
assessed in parallel. Top left, Western blot detection of zDHHC17-Cub-PLV truncation mutants (anti-VP16 antibody) and 
NubG-2HA-CSP/ SNAP25 (anti-HA antibody) from haploid-yeast lysates, along with positions of molecular weight 
markers. (C) Interaction of GST-tagged, N-terminal cytosolic domain (amino acids11–305) of zDHHC17 (GST-17NAnk) 
with SNAP25 and CSP from rat brain. GST-precleared rat brain lysate was incubated with glutathione beads and either 
GST or GST-17NAnk; bound proteins were eluted after boiling in sample buffer and centrifugation. Input (I; 0.2%), 
unbound (U; 0.2%), and bound fractions (B; 1%) were subjected to SDS–PAGE, transfer to nitrocellulose, Ponceau-S 
staining, and Western blot analysis using the antibodies indicated. Positions of molecular weight markers are shown on 
the left. (D) Top, interaction of GST-17NAnk with palmitoylated (p) and nonpalmitoylated (np) Myc-tagged CSP. 
HEK293T cells were either transfected with Myc-CSP alone or cotransfected with Myc-CSP and HA-zDHHC3 plasmids; 
precleared HEK293T lysate was incubated with glutathione beads and purified GST or GST-17NAnk; bound proteins 
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S-acylation too, a protein that appears to be both a substrate and 
regulator of this enzyme (Huang et al., 2009, 2011).
In addition to the ANK domain and catalytic DHHC-CR domain, 
the cytoplasmic C-terminus of zDHHC17 was also found to be es-
sential for substrate S-acylation. Although it is possible that the C-
terminus may couple to substrate proteins to facilitate S-acyl trans-
fer, it is very unlikely that binding per se, and thus initial substrate 
recruitment, requires this region, since we did not observe any loss 
of binding to SNAP25 or CSP when this domain was deleted. Thus, 
this region is probably required for other steps of S-acylation, linked 
to the ability of zDHHC17 to form acyl intermediates and/or transfer 
them to the recruited proteins.
Binding of zDHHC3/zDHHC7 to SNAP25 and CSP was either 
very weak (SUS) or undetectable (pull downs). Nevertheless, 
zDHHC3 and zDHHC7 appeared to catalyze S-acylation of SNAP25/
CSP more efficiently than zDHHC17, whereas zDHHC13 was inac-
tive toward these proteins. Hence the much-increased S-acylation 
efficiency of zDHHC3/7 to SNAP25/CSP relative to zDHHC17/13 
must be a result of the intrinsic ability of these enzymes to transfer 
acyl groups to target proteins. Indeed, autoacylation, which is often 
used as a measure of S-acylation activity, was previously found to be 
higher for zDHHC3 and zDHHC7 than for zDHHC17 and zDHHC13, 
with the latter exhibiting the lowest autoacylation activity (Ohno 
et al., 2012; Ren et al., 2013); this agrees with what we observed in 
our S-acylation assays (this study) and previous membrane targeting 
assays (Greaves et al., 2008, 2009, 2010) with these sets of enzymes 
and substrates. Similarly, we also observed prominent autoacylation 
of zDHHC3 and zDHHC7, but no detectable S-acylation for 
zDHHC17 and zDHHC13, in our S-acylation assays. Although some 
zDHHC enzymes have been shown to be S-acylated outside their 
DHHC domains (Yang et al., 2010), there is no evidence that acyl 
chains are present outside the DHHC domain of zDHHC3/7, and so 
this is unlikely to explain the increased autoacylation of these pro-
teins relative to zDHHC17/13. Lack of substrate specificity and in-
creased rate of S-acyl-transfer in zDHHC3- and zDHHC7-catalyzed 
reactions could explain not only why these enzymes are so versatile 
in the number of substrates they can S-acylate in various in-cell S-
acylation assays, but also why most of the substrates are shared for 
these two enzymes (Greaves and Chamberlain, 2011).
Although the data presented clearly show that zDHHC3 and 
zDHHC7 are much more capable of S-acylating SNAP25 and CSP 
than zDHHC17 (or zDHHC13), additional factors may influence the 
in vivo S-acylation of these substrates by endogenously expressed 
enzymes, including 1) the cell-specific expression levels of various 
zDHHC-enzymes, 2) their possible compartmentalization within 
different subdomains of the Golgi, which might influence substrate 
accessibility, and 3) their affinity to (and/or local availability of) acyl-
CoA as a substrate in the S-acylation reaction.
The lack of positive correlation between the strength of zDHHC–
substrate interactions and S-acylation efficiency was most pro-
nounced for zDHHC13, which bound tightly to SNAP25 and CSP 
but failed to S-acylate these proteins. To investigate why zDHHC13 
has no detectable S-acylation activity toward CSP and SNAP25, we 
used two approaches: 1) swapping zDHHC13’s and zDHHC17’s 
cytosolic NAnk domains, and 2) swapping the DQHC/ DHHC motifs 
are functionally interchangeable. Although zDHHC13 having the 
NAnk domain of zDHHC17 (13-NAnk17; Figure 7A) remained inac-
tive toward either SNAP25 or CSP (Figure 7, B and C), zDHHC17 
containing the NAnk domain of zDHHC13 (17-NAnk13; Figure 7A) 
became largely inactive too, losing completely its ability to S-acylate 
CSP (Figure 7C) and retaining only partial activity against SNAP25 
(Figure 7B). Swapping of the NAnk domains did not result in altered 
Golgi localization of either of the two enzymes (Figure 7D). Thus, 
although the NAnk domain of zDHHC13 interacts with both SNAP25 
and CSP, it cannot efficiently support the S-acylation of these sub-
strates by an adjacent zDHHC13 or zDHHC17 core.
Introducing a DQHC motif into zDHHC17 blocks S-acylation 
of SNAP25 and CSP
The fact that coexpression of zDHHC13 does not promote S-acyla-
tion of either SNAP25 or CSP (Greaves et al., 2008) is somewhat 
surprising, given that zDHHC13 interacts efficiently with these sub-
strates, as observed with both SUS analysis and pull-down experi-
ments. However, one conspicuous feature of zDHHC13 distinguish-
ing it from all other mammalian DHHC enzymes is its unique DQHC 
motif, which could limit S-acyl-transferase activity and thus restrict 
the substrates to be S-acylated. A histidine-to-alanine mutation in 
the equivalent position of yeast Erf2 was previously shown to inacti-
vate the enzyme, by reducing the rate of palmitoyl-Erf2 intermedi-
ate formation, and abolishing the palmitate transfer to Ras2 sub-
strate (Mitchell et al., 2010). To investigate how the DQHC motif 
might affect zDHHC13 S-acyl-transferase activity, we introduced a 
DHHC motif into zDHHC13 and a DQHC motif into zDHHC17. Al-
though the introduction of a DQHC motif (H465Q mutation; Figure 
8A) into zDHHC17 completely abolished the ability of this enzyme 
to S-acylate either SNAP25 or CSP, zDHHC13 containing a DHHC 
motif (Q454H mutation; Figure 8A) remained inactive toward both 
SNAP25 and CSP (Figure 8, B and C). None of these mutations al-
tered zDHHC13/17 localization (Figure 8D). Hence, although H465 
is necessary for zDHHC17 activity, Q454 at the equivalent position 
of zDHHC13 cannot account on its own for zDHHC13’s inactivity 
toward CSP and SNAP25.
DISCUSSION
The results presented in this study identify vast differences in sub-
strate affinity and S-acyl-transferase activity among Golgi zDHHC 
enzymes, with zDHHC17 and zDHHC13 being equipped for protein 
binding, and zDHHC3 and zDHHC7 being highly efficient in protein 
S-acylation.
The zDHHC17 and zDHHC13 S-acyl-transferases were found to 
display strong and specific interactions with CSP and SNAP25; these 
interactions were mediated by a seven-ankyrin repeat domain 
(absent in other S-acyl-transferases) located in the cytosolic N-ter-
mini of these enzymes. Ankyrin repeats exist in numerous proteins, 
and they all serve a sole function: mediating protein–protein interac-
tions (Li et al., 2006). Hence the ANK domain of zDHHC17 and 13 
may be well fitted to be the recruiting module, at least for zDHHC17, 
for S-acylation of zDHHC17 substrates. Indeed, complete deletion 
of this module resulted in impaired CSP/SNAP25 S-acylation (this 
study), whereas partial deletion was shown to affect huntingtin (HTT) 
were eluted after boiling in sample buffer and centrifugation. Input (I; 6%), unbound (U; 5%), and bound fractions 
(B; 20%) were subjected to SDS–PAGE, transfer to nitrocellulose, Ponceau-S staining, and Western blot analysis using 
anti-Myc antibody. Positions of molecular weight markers are shown on the left. Bottom, percentage of Myc-CSP 
recovered was quantified for both p and np (n  4; error bars, SEM), and differences were statistically analyzed by 
unpaired Student’s t test (***p < 0.001).
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FIGURE 4: The ANK domain and cytosolic C-terminal domain of zDHHC17 are required for S-acylation of SNAP25 and 
CSP. HEK293T cells were cotransfected with EGFP-SNAP25 (A) or EGFP-CSP (B), and an appropriate amount of the 
indicated HA-tagged zDHHC17 constructs (per well) or control (empty HA-pEF-BOS vector) to achieve similar zDHHC17 
expression levels (17-WT and 17-$N, 2.4 µg;17-$NAnk and control, 3.2 µg; 17-$C, 1.6 µg). EGFP-SNAP25 and HA-zDHHC 
enzymes were detected by immunoblotting with GFP and HA antibodies, respectively, and incorporation of radiolabel 
was detected with the aid of a Kodak Biomax Transcreen LE. Positions of molecular weight markers are shown on the left. 
SNAP25 palmitoylation was assessed by the amount of 3H-palmitic acid incorporated (after metabolic labeling) relative to 
protein levels, and CSP palmitoylation was assessed, after separation of its palmitoylated (p) and nonpalmitoylated (np) 
forms by SDS–PAGE of cell lysates and immunoblotting with GFP, by calculating the ratio of palmitoylated EGFP-CSP (p) 
to the total protein (p + np). Percentage increase in palmitoylation (vs. control) was quantified (n  4; error bars, SEM) and 
differences from 17-WT were analyzed by Tukey posttest, following a one-way analysis of variance (ANOVA; n.s., p q 0.05, 
*p < 0.05, **p < 0.01, ***p < 0.001). Subcellular distribution of zDHHC17 constructs was assessed by cotransfection with 
Golgi marker GRASP65 (mCherry construct) and immunofluorescence using an HA antibody (C). Scale bars, 5 µm.
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FIGURE 5: zDHHC13 interacts with CSP and SNAP25 via its NAnk domain. (A). Schematic diagram of zDHHC13 
transmembrane constructs (13-WT, 13-$NAnk, and 13-$CDHHC) used for SUS analysis and of zDHHC17/13 cytosolic 
constructs (17-NAnk and 13-NAnk) used for pull-down assays. Comparison of zDHHC–CSP/SNAP25 interactions between 
zDHHC7 and zDHHC13 (B) or among different transmembrane zDHHC13 constructs (C) was assayed using the mating-
based SUS (growth assay). zDHHC–CSP/SNAP25 matings at corresponding OD600 were dropped on SD medium 
supplemented with adenine and histidine to verify equal dropping densities, and on SD medium (supplemented or not with 
50 µM methionine) to verify interactions. For comparison of interactions between zDHHC7 and zDHHC13, plates were 
scanned after incubation at 30°C for 4 d, whereas for comparison of interactions between zDHHC13 truncation mutants 
and wild type, plates were scanned after incubation at 30°C for the appropriate number of days (indicated) to achieve 
similar NubI-mating growth among different zDHHC13 constructs. Spontaneous reassembly of the C-terminal ubiquitin of 
zDHHC13-Cub-PLV with wild-type (NubI) or mutated (NubG) N-terminal ubiquitin was assessed in parallel. Protein levels of 
zDHHC-Cub-PLV truncation mutants were assessed by Western blotting, using an anti-VP16 antibody, with positions of 
molecular weight markers shown on the left of the blots. Assessment of His6-SNAP25 (D) and His6-CSP (E) binding to 
HA-tagged 17-NAnk, 13-NAnk, and full-length zDHHC13 (13-WT) was assayed by pull-down assays, as in Figure 1.
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within their zDHHC-CR region. Both approaches failed to activate 
zDHHC13 to S-acylate either SNAP25 or CSP. However, in both 
cases, the ability of zDHHC17 to modify these substrates was per-
turbed. Thus, there may be a difference in the way the NAnk do-
mains of these enzymes present substrates to the catalytic domain. 
In addition, the DQHC motif in zDHHC13, although detrimental for 
zDHHC17 (and potentially for zDHHC13) S-acylation activity, cannot 
account on its own for zDHHC13’s inability to modify these 
substrates. zDHHC13 has been shown to be the only other S-acyl-
transferase apart from zDHHC17 to efficiently interact with, and 
S-acylate, HTT (Huang et al., 2011) and ClipR59 (Ren et al., 2013), 
but has not been found to have any activity toward other zDHHC17’s 
substrates. We propose that the DQHC motif negatively affects 
zDHHC13’s acyl-transfer ability, and thus its S-acylation ability is 
restricted to strongly bound substrates with appropriate orientation, 
limiting the substrates that can be S-acylated by this enzyme. Hence 
CSP and SNAP25, unlike HTT and ClipR59, may lack the orientation 
required upon binding for efficient S-acylation by zDHHC13. Of 
interest, however, a small but significant reduction of SNAP25 S-
acylation was observed in zDHHC13-deficient mice (Sutton et al., 
2013). Because in-cell S-acylation assays do not indicate S-acyl-
transferase activity of zDHHC13 toward SNAP25, it is possible that 
this enzyme contributes indirectly to SNAP25 in vivo S-acylation, 
perhaps by recruiting it to the Golgi for S-acylation by other zDHHCs. 
Indeed, it will be interesting in future studies to confirm that the abil-
ity of zDHHC13 to increase S-acylation of HTT and ClipR59 is lost 
after mutation of its catalytic cysteine. This will rule out any indirect 
effect of zDHHC13 on the S-acylation of these substrates.
Although we focused on the role of zDHHC17 and zDHHC13 as 
S-acyl-transferases, the participation of the ANK domain of these 
enzymes in wider protein interaction networks may contribute to its 
cellular functions, independently of S-acyl-transferase function. In-
deed, the unusually high proportion of interacting proteins shared 
by zDHHC17 and HTT, including the (non–S-acylated by zDHHC17) 
optineurin (Butland et al., 2014), indicates the existence of such 
complexes inside the cell. Furthermore, an S-acylation–independent 
scaffolding function for the ANK domain of zDHHC17 resulting in 
JNK3 phosphorylation has been documented (Yang and Cynader, 
2011).
Our work also highlights the strength of the yeast split-ubiquitin 
system for the study of protein interactions between full-length, 
membrane-inserted zDHHC enzymes and their substrates. Although 
various factors that could influence zDHHC–substrate interactions, 
including other interacting partners or posttranslational modifica-
tions, may not be faithfully recapitulated in yeast cells, this system 
offers a valuable mechanism with which to interrogate the underly-
ing mechanisms that govern specificity of zDHHC–substrate interac-
tions. Indeed, we verified the findings made using this system with 
pull-down experiments from mammalian cell extracts. In future work, 
it will be interesting to implement techniques that allow zDHHC–
substrate interactions to be monitored in real time in mammalian 
FIGURE 6: zDHHC3 and zDHHC7 can S-acylate CSP and SNAP25 
more efficiently than zDHHC17, whereas zDHHC13 is inactive toward 
these substrates. (A) S-acylation of SNAP25 by zDHHC3, 17, 7, and 
13. HEK293T cells were cotransfected with EGFP-SNAP25 and the 
indicated HA-tagged zDHHCs (or empty vector as control) and 
labeled with 3H-palmitate as described in Materials and Methods. 
EGFP-SNAP25 and HA-zDHHC enzymes were detected by 
immunoblotting with GFP and HA antibodies, respectively, and 
incorporation of radiolabel was detected with the aid of a Kodak 
Biomax Transcreen LE. Positions of molecular weight markers are 
shown on the left. Arrowhead indicates autoacylated zDHHC3/
zDHHC7. SNAP25 palmitoylation was assessed by the amount of 
3H-palmitic acid incorporated relative to protein level. Percentage 
increase in palmitoylation (vs. control) was quantified (n  4; error 
bars, SEM), and differences from zDHHC17-induced palmitoylation 
were analyzed by Tukey posttest, following a one-way ANOVA (*p < 
0.05, **p < 0.01, ***p < 0.001). (B) S-acylation of CSP by zDHHC3, 17, 
7, and 13. HEK293T cells were cotransfected with EGFP-CSP and the 
indicated HA-tagged zDHHC. EGFP-CSP and HA-zDHHC enzymes 
were detected by immunoblotting with GFP and HA antibodies, 
respectively. CSP palmitoylation was assessed, after separation of its 
palmitoylated (p) and nonpalmitoylated (np) forms by SDS–PAGE of 
cell lysates, by calculating the ratio of palmitoylated EGFP-CSP (p) to 
the total protein (p + np). Percentage increase in palmitoylation (vs. 
control) was quantified (n  4; error bars, SEM), and differences from 
zDHHC17-induced palmitoylation were analyzed by Tukey posttest, 
following a one-way ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001).
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FIGURE 7: The ankyrin-repeat-containing cytosolic domains of zDHHC13 and zDHHC17 are not interchangeable.  
(A) Schematic diagram of zDHHC17/13 chimeras used for S-acylation assays. HEK293T cells were cotransfected with 
EGFP-SNAP25 or EGFP-CSP and the indicated HA-tagged zDHHC. EGFP-SNAP25, EGFP-CSP, and HA-zDHHC enzymes 
were detected by immunoblotting with GFP and HA antibodies, respectively, and incorporation of radiolabel was 
detected with the aid of a Kodak Biomax Transcreen LE. Positions of molecular weight markers are shown on the left. 
SNAP25 palmitoylation was assessed by the amount of 3H-palmitic acid incorporated (following metabolic labeling) 
relative to protein level (B), and CSP palmitoylation was assessed, after separation of its palmitoylated (p) and 
nonpalmitoylated (np) forms by SDS–PAGE of cell lysates, by calculating the ratio of palmitoylated EGFP-CSP (p) to the 
total protein (p + np). (C) Percentage increase in palmitoylation (vs. control) was quantified (SNAP25, n  10; CSP, n  4; 
error bars, SEM). Statistical analysis was performed using a one-way ANOVA and Tukey posttest (n.s., p q 0.05, *p < 0.05, 
**p < 0.01, ***p < 0.001). (D) Subcellular distribution of zDHHC17/13 constructs was assessed by cotransfection with 
Golgi marker GRASP65 (mCherry construct) and immunofluorescence using an HA antibody. Scale bars, 5 µm.
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FIGURE 8: Effect of the DQHC/DHHC motif in zDHHC13 and zDHHC17 on S-acylation of SNAP25 and CSP. 
(A) Schematic diagram of zDHHC17/13 mutants used for S-acylation assays. HEK293T cells were cotransfected with 
either EGFP-SNAP25 or EGFP-CSP and the indicated HA-tagged zDHHC construct. EGFP-SNAP25, EGFP-CSP, and 
HA-zDHHC enzymes were detected by immunoblotting with GFP and HA antibodies, respectively, and incorporation of 
radiolabel was detected with the aid of a Kodak Biomax Transcreen LE. Positions of molecular weight markers are shown 
on the left. SNAP25 palmitoylation was assessed by the amount of 3H-palmitic acid incorporated (after metabolic 
labeling) relative to protein level (B), and CSP palmitoylation was assessed after separation of its palmitoylated (p) and 
nonpalmitoylated (np) forms by SDS–PAGE of cell lysates by calculating the ratio of palmitoylated EGFP-CSP (p) to the 
total protein (p + np). (C) Percentage increase in palmitoylation (vs. control) was quantified (SNAP25, n  4; CSP, n  6; 
error bars, SEM). Statistical analysis was performed using a one-way ANOVA and Tukey posttest (n.s., p q 0.05, *p < 0.05, 
**p < 0.01, ***p < 0.001). (D) Subcellular distribution of zDHHC17/13 mutants was assessed by cotransfection with Golgi 
marker GRASP65 (mCherry construct) and immunofluorescence using an HA antibody. Scale bars, 5 µm.
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by site-directed mutagenesis. The GST-17NAnk construct was 
produced by subcloning the zDHHC17 cDNA corresponding to 
amino acids 11–305 into pGEX-KG vector. For the mating-based 
SUS, all cDNAs were cloned by Gateway technology (Life Technolo-
gies, Paisley, United Kingdom), first as entry clones in pDONR207 
and then as destination clones in the corresponding destination 
vector; zDHHC enzyme cDNAs (without a STOP codon) were in-
serted in pMetYC-Dest (Grefen et al., 2001) for expression of 
zDHHC-ProteinA-LexA-VP16 protein, whereas CSP and SNAP25 
cDNAs (having a STOP codon) were inserted into pNX35-Dest 
(Grefen and Blatt, 2012) for expression of NubG-HA-CSP and NubG-
HA-SNAP25 proteins. His6-tagged CSP and SNAP25 were also pro-
duced by Gateway cloning, using the foregoing CSP and SNAP25 
cDNAs and Gateway compatible pET-28B as destination vector. For 
mammalian cell expression of zDHHC17 truncation mutants, corre-
sponding cDNAs were inserted by Gateway technology to Gate-
way-compatible HA-pEF-BOS, and STOP codons were inserted 
afterward, for expression of HA-zDHHC17 proteins.
Protein purification
Plasmids encoding the proteins to be purified were inserted into 
BL21(DE3)pLysS bacterial cells (Promega, Southampton, United 
Kingdom), and protein expression was induced by addition of 1 mM 
isopropyl-B-D-thiogalactoside in culture medium. For GST/GST-
17NAnk purification, bacterial lysates were incubated with glutathi-
one Sepharose 4B (GE Healthcare, Little Chalfont, United Kingdom), 
and after extensive washing with PBS, proteins were eluted by incu-
bation in 50 mM Tris, pH 8, containing 10 mM reduced glutathione. 
For His6-CSP/SNAP25, bacterial lysates were incubated with Ni
2+-
NTA agarose (Qiagen, Manchester, United Kingdom), and after ex-
tensive washing with Washing buffer I (40 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid [HEPES], pH 8, 300 mM NaCl, 40 mM 
imidazole), proteins were eluted by incubation with Elution buffer 
(same as Washing buffer, but with 500 mM imidazole added). All 
eluted proteins were dialyzed overnight against 5 l of ice-cold phos-
phate-buffered saline (PBS) and subsequently kept in aliquots at 
80°C. Protein purity and concentration of dialyzed samples were 
assessed, after SDS–PAGE, by Bio-safe Coomassie staining (Bio-Rad, 
Hemel Hempstead, United Kingdom) and quantification of bands 
against bovine serum albumin (BSA) standards (Fisher Scientific, 
Loughborough, United Kingdom) run in parallel.
Antibodies
Mouse GFP antibody (JL8) was from Clontech (California). Rat HA 
antibody (immunoblotting) was from Roche (Sussex, United King-
dom), and mouse HA antibody (immunofluorescence) was from 
Cambridge Bioscience (Cambridge, United Kingdom). Mouse 
SNAP25 antibody (SMI-81) was from Covance (New Jersey). Rabbit 
CSP antibody was from Enzo Life Sciences (Exeter, United Kingdom). 
Rabbit synuclein (ab52168), Myc (ab9106), and VP16 (ab4808) anti-
bodies were from Abcam (Cambridge, United Kingdom). Alexa 
Fluor secondary antibodies used for immunofluorescence were from 
Life Technologies. IRDye mouse and rabbit secondary antibodies 
were from LI-COR (Cambridge, United Kingdom) and DyLight rat 
ones from Fisher Scientific.
Cell culture and transfection
HEK293T cells were maintained in DMEM (Life Technologies) 
supplemented with 10% fetal bovine serum in a humidified atmo-
sphere containing 5% CO2. Cells were plated onto poly-D-lysine–
coated 24-well plates for S-acylation assays or coverslips for 
immunofluorescence analysis. Transfections were performed using 
cells; this could be achieved through the use of Forster resonance 
energy transfer experiments using fluorescently tagged proteins. In 
addition, in vitro kinetic analysis with recombinant proteins is likely 
to shed more light on the differences in autoacylation and substrate 
S-acylation among various zDHHC enzymes (Jennings and Linder, 
2012) observed in the present study.
What role might selective and nonselective S-acylation of sub-
strate proteins by different zDHHC enzymes serve in the cell? For 
peripheral membrane proteins, an important requirement for S-acy-
lation is that substrate proteins have a mechanism to associate tran-
siently with cell membranes to allow their recognition by membrane-
bound zDHHC enzymes. Proteins such as Ras use farnesylation as 
this initial membrane targeting signal, whereas SNAP25 and CSP 
appear to have a weak intrinsic membrane affinity (Greaves et al., 
2008, 2009). The strength of this initial membrane interaction of 
nonacylated proteins would be the major factor that dictates how 
efficiently they become modified by an S-acylation machinery that 
lacks any specificity or mechanism of substrate recruitment. How-
ever the presence of enzymes such as zDHHC17, which interact 
more strongly with their substrates, may be important to ensure the 
efficient S-acylation of substrates that have weaker membrane affini-
ties. Indeed, previous work in our lab suggests that disruption of the 
interaction of SNAP25 with zDHHC17 leads to a loss of stable mem-
brane binding of this protein in neuroendocrine cells (Greaves et al., 
2009), showing the importance of zDHHC–substrate specificity for 
S-acylation and intracellular targeting of this protein. Specificity in 
zDHHC–substrate interactions is not limited to zDHHC17/zDHHC13, 
as the PDZ ligands of zDHHC5 and zDHHC8 are involved in recogni-
tion of at least some of their substrates (Thomas et al., 2012). The 
differences in substrate binding and S-acylation efficiencies among 
zDHHCs, which are demonstrated in this study, imply vast differ-
ences in their S-acyl-transferase activities. Such diversity in S-acyl-
transfer ability among zDHHC enzymes, combined with their over-
lapping substrate specificities, reveals great complexity in the way in 
which various zDHHC substrates are processed inside the cell to 
achieve certain subcellular localizations.
MATERIALS AND METHODS
Chemicals
Unless otherwise stated, all chemicals were purchased from Sigma 
(Dorset, United Kingdom).
Plasmids
EGFP-tagged SNAP25 and CSP were produced as previously de-
scribed (Greaves and Chamberlain, 2006; Greaves et al., 2009). 
Plasmid DNA encoding mouse HA-tagged zDHHC3, zDHHC7, 
zDHHC13, and zDHHC17 was kindly provided by Masaki Fukata 
(National Institute of Physiological Sciences, Osaka, Japan; Fukata 
et al., 2004). Owing to a slightly different nomenclature used for the 
DHHC clones synthesized by the Fukata lab, zDHHC13 used in this 
study is the original DHHC22 clone (Fukata et al., 2004; Greaves 
et al., 2008, 2010); the National Center for Biotechnology Informa-
tion (NCBI) reference for mouse zDHHC13 used here is NP_082307.1. 
The HA-zDHHC17 clone used here was that originally generated by 
the Fukata lab (Fukata et al., 2004) encompassing amino acids 
11–632 according to NCBI reference NP_766142.2. ANK-domain 
swaps to generate 13-NAnk17 and 17-NAnk13 mutants were cen-
tered on amino acid N288 of zDHHC17 and N278 of zDHHC13. 
Briefly, restriction sites were introduced before the initiating methi-
onine and after residue N288/N278 of the zDHHC enzymes by site-
directed mutagenesis. After swapping of these regions into the cor-
responding zDHHC enzyme, the restriction sites were removed 
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prevents spontaneous reconstruction of ubiquitin, which could occur 
in the absence of interaction if wild-type Nub (designated NubI) is 
used instead. A schematic of the SUS principle is shown in Figure 2A. 
Owing to the PLV being attached to the bait rather than the prey, the 
concentration of the latter has very little effect on reporter gene acti-
vation and hence on yeast growth; on the contrary, decreased 
concentration of bait can lead to reduced yeast growth, whereas its 
increased concentration can produce a strong reporter activation re-
sponse even in limiting concentrations of the prey or in weak bait–
prey interactions. Nevertheless, this can be overcome by addition of 
methionine in the yeast growth medium, which will restrict bait ex-
pression due to met25, a methionine repressible promoter in pMe-
tYC-Dest (bait) plasmid (Grefen et al., 2001). Yeast transformation, 
mating, growth media preparation, and lysis of haploid yeast for 
Western blotting were done as described previously (Grefen et al., 
2009). Briefly, overnight cultures of matings were resuspended in 
sterile water at indicated OD600, and 5 µl of each mating was dropped 
on synthetic defined (SD) medium (supplemented or not with methi-
onine) for assessment of interactions and on SD media supplemented 
with adenine and histidine for verification of matings and yeast cell 
density. Plates were placed at 30°C and were scanned after incuba-
tion for the number of days indicated in the corresponding figure. 
When interactions of different baits were compared, all matings were 
grown for the same number of days; however, when bait expression, 
and thus corresponding NubI-mating growth, varied considerably, 
matings were incubated for an appropriate number of days to 
achieve similar (for all baits) growth with control prey (NubI).
Pull-down assays
For GST pull down of rat-brain proteins, rat brain was lysed in 1.5 ml 
of lysis buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 1% Triton 
X-100, and protease inhibitor cocktail) using a Dounce homogenizer, 
and the lysate was centrifuged (12,000 r g for 10 min at 4°C) to re-
move insoluble material. The supernatant was precleared by incu-
bation with 250 µg of purified GST and 1 ml of glutathione-Sephar-
ose beads for 2 h at 4°C. The cleared lysate was split into halves, 
and each half was incubated with 200 µl of glutathione beads and 
either 250 µg of purified GST or an equimolar quantity of purified 
GST-17NAnk (474 µg) overnight at 4°C. Unbound fractions were col-
lected after centrifugation, and bound proteins were eluted, after 
extensive wash with lysis buffer, by boiling in sample buffer. A similar 
procedure was followed for the pull down of Myc-CSP from HEK293T 
cells. For His6-CSP and His6-SNAP25 pull down of HA-zDHHC en-
zymes, the procedure was as follows: HEK293T cells expressing the 
corresponding HA-zDHHC plasmids were lysed in 600 µl Binding 
buffer (20 mM Tris, pH 7.9, 150 mM NaCl, 1% Triton X-100, 20 mM 
imidazole, 20 mM 2-mercaptoethanol) and cleared by centrifuga-
tion (10,000 r g for 10 min at 4°C). A 240-µl amount of the superna-
tant was incubated for 2 h at 4°C with either 75 µg of purified His6-
tagged SNAP25 (or equivalent amount of PBS) and 25 µl of 
Ni2+- nitriloacetic acid (NTA) agarose (Qiagen) or with 25 µl of Ni2+-
NTA agarose (Qiagen) that had been preincubated with 75 µg of 
purified His6-tagged CSP for 30 min at 4°C. After extensive washing 
with Washing buffer II (same as Binding buffer but having 300 mM 
NaCl and 60 mM imidazole instead), bound proteins were recov-
ered by boiling in sample buffer.
Quantification of blots and statistical analysis
Quantification of bands in 3H fluorographs and immunoblots was 
performed by densitometry, using ImageJ (National Institutes of 
Health, Bethesda, MD) software. All statistical tests were performed 
with Prism software (GraphPad, La Jolla, CA).
Lipofectamine 2000 according to the manufacturer’s instructions 
(Life Technologies). Cotransfections with EGFP-substrate and HA-
zDHHC plasmids for biochemical experiments used 0.8 and 1.6 µg 
respectively, unless otherwise stated. For immunofluorescence, 
0.5 µg of plasmid DNA was used for transfections. Cells were ana-
lyzed ^20 h posttransfection.
Immunofluorescence
HEK293T cells were transfected with 0.2 µg each of HA-DHHC17/13 
and GRASP65-mCherry and incubated overnight at 37°C/5% CO2 
in a humidified atmosphere. Cells were then fixed in 4% formalde-
hyde and permeabilized by incubating in PBS containing 0.3% BSA 
and 0.25% Triton X-100 for 6 min at room temperature. The per-
meabilized cells were washed and incubated for 60 min in PBS-BSA 
containing mouse HA antibody (1:50 dilution). The cells were 
washed again in PBS-BSA and incubated for 60 min in PBS-BSA 
containing anti-mouse antibody conjugated to Alexa Fluor 488 
(1:400 dilution). The labeled cells were washed in PBS and briefly 
submerged in distilled H2O before being mounted onto glass slides 
using Mowiol. Cells were imaged using a Leica SP5 confocal micro-
scope. Scale bars represent 5 µm.
S-acylation assays
For analysis of SNAP25 S-acylation, transfected cells on 24-well 
plates were incubated for 30 min in DMEM containing 1% defatted 
BSA and then incubated in the same medium containing 0.5 mCi/ml 
3H-palmitic acid for 3–4 h at 37o C. The labeled cells were washed in 
PBS, lysed, and boiled in SDS-dissociation buffer (2% SDS, 25 mM 
dithiothreitol, 10% glycerol, 0.01% bromophenol blue, 50 mM Tris, 
pH 6.8), subjected to SDS–PAGE, and transferred onto nitrocellu-
lose for immunoblotting analysis or 3H-palmitate detection, which 
relied on exposing the blots to light-sensitive film in the presence 
of a Kodak Biomax Transcreen LE (PerkinElmer, Seer Green, United 
Kingdom) for 4–18 d in the dark at 80°C. CSP S-acylation status 
was determined by a well-characterized change in migration pattern 
on SDS–PAGE gels (Chamberlain et al., 2001; Greaves and 
Chamberlain, 2006; Greaves et al., 2008, 2012), since this assay 
does not rely on radioactivity and can produce more accurate mea-
surements of S-acylation due to quantification of both palmitoylated 
and total protein in the same gel. SDS–PAGE was performed using 
12% polyacrylamide gels. After S-acylation of CSP, marked (^7 kDa) 
reduction in migration was observed.
Mating-based split-ubiquitin system 
The mating-based SUS in yeast is a very sensitive method for the 
detection of protein–protein interactions in vivo; this technique is 
specifically applicable for transmembrane proteins (Grefen et al., 
2009) and hence can be used for the study of zDHHC enzyme inter-
actions with other proteins. It relies on ubiquitin split into halves: the 
C-terminal half (Cub) is fused in between a transmembrane (bait) pro-
tein and a transcriptional reporter complex (PLV), whereas the N-ter-
minal half (Nub) is fused to a prey protein. Bait and prey are initially 
expressed in different types of yeast; upon mating of these, bait and 
prey are coexpressed in the same cell, and their interaction leads to 
the reassembly of the ubiquitin molecule. The whole ubiquitin can 
be thus recognized by ubiquitin-specific proteases, which will cleave 
downstream of Cub, leading to the release of the PLV complex and 
subsequent activation of different reporter genes; of these, Ade2 
and His3 encode for proteins required for synthesis of adenine and 
histidine, and thus their expression allows the yeast to grow on selec-
tive media lacking these two nutrients (growth assay). A point muta-
tion (I13G) into the N-terminal half of ubiquitin (designated NubG) 
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